Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Arcadia Biosciences, Inc. (RKDA) Stock Forecast 2025 - AI Price Prediction & Analysis

Arcadia Biosciences, Inc. (RKDA) AI Stock Price Forecast & Investment Analysis

Arcadia Biosciences, Inc. Stock Price Chart and Technical Analysis

Loading Arcadia Biosciences, Inc. interactive price chart and technical analysis...

Arcadia Biosciences, Inc. (RKDA) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

Arcadia Biosciences, Inc. (Stock Symbol: RKDA) is a leading company in the Energy & Transportation sector , specifically operating within the Crude Petroleum & Natural Gas industry. The organization employs approximately 42 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $5 million generating a -544.2% net profit margin .

Market Capitalization: $6 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -49.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Arcadia Biosciences, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

Arcadia Biosciences, Inc. strategically competes in the highly dynamic Crude Petroleum & Natural Gas marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . The company maintains a healthy -28.4% gross margin, indicating strong pricing power and operational efficiency.

Arcadia Biosciences, Inc. (RKDA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Arcadia Biosciences, Inc. stock analysis.

Loading Arcadia Biosciences, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Arcadia Biosciences, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Arcadia Biosciences, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Arcadia Biosciences, Inc.: With a P/E ratio of -1.42, the market sees the stock as potentially undervalued.

P/E Ratio -1.42x
P/B Ratio 0.94x
Market Cap $6M
EPS $-5.53
Book Value/Share $4.55
Revenue/Share $0.16
FCF/Share $-3.33
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Arcadia Biosciences, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Arcadia Biosciences, Inc.: An ROE of -49.9% indicates room for improvement in shareholder value creation.

ROE -49.9%
ROA -32.1%
ROIC -41.0%
Gross Margin -28.4%
Operating Margin -383.1%
Net Margin -544.2%
EBT Margin -237.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Arcadia Biosciences, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Arcadia Biosciences, Inc.: A current ratio of 7.02 indicates strong liquidity.

Current Ratio 7.02x
Quick Ratio 5.96x
D/E Ratio 0.07x
Financial Leverage 1.41x
Interest Coverage -805.6x
Working Capital $25M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Arcadia Biosciences, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Arcadia Biosciences, Inc.: Free cash flow of $-27M indicates cash challenges that need attention.

Operating Cash Flow $-26M
Free Cash Flow $-27M
Capital Spending $-1M
FCF/Sales -396.4%
CapEx/Sales 14.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Arcadia Biosciences, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Arcadia Biosciences, Inc.: An asset turnover of 0.15x suggests room for improvement in asset utilization.

Asset Turnover 0.15x
Receivables Turnover 4.9x
Inventory Turnover 2.1x
Fixed Assets Turnover 0.9x
Days Sales Outstanding 75 days
Days Inventory 173 days
Payables Period 45 days
Cash Conversion Cycle 203 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Arcadia Biosciences, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Arcadia Biosciences, Inc.: With annual revenue of $5M, Arcadia Biosciences, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $5M
Operating Income $-14M
Net Income $-21M
R&D Expense $7M
SG&A Expense $338M
Cost of Goods Sold $3M
Balance Sheet Highlights ($ Millions)
Total Current Assets $81M
Cash & Short-term Investments $63M
Total Liabilities $22M
Short-term Debt $0M
Accounts Receivable $7M
Inventory $8M
Dividend & Shareholder Information
Shares Outstanding 1M
Growth Metrics (YoY)
EPS Growth -63.6%

Latest Arcadia Biosciences, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Arcadia Biosciences, Inc. (RKDA) stock price and investment outlook.

, source: Yahoo Finance

Q3 2024 Arcadia Biosciences Inc Earnings CallGood afternoon, and thank you to everyone on the call for joining us today to discuss our 2024 third-quarter financial results. When we last spoke in ...

, source: Yahoo Finance

Q4 2024 Arcadia Biosciences Inc Earnings CallThank you and good afternoon. Joining me on the call today is T.J. Schaefer, Arcadia's President and Chief Executive Officer. This call is being ...

Arcadia Biosciences, Inc. Competitors & Peer Analysis - Energy & Transportation Sector

Comparative analysis of Arcadia Biosciences, Inc. against industry peers and competitors in the Energy & Transportation sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AESI Unlock Forecast $1449M 103.6x 1.1x
ALTX Unlock Forecast $4M x 2.9x
AMPY Unlock Forecast $132M 11.7x 0.3x
ANNA Unlock Forecast $M x x
ANNAW Unlock Forecast $M x x
APA Unlock Forecast $9826M 8.0x 1.7x
AR Unlock Forecast $10271M 22.8x 1.4x
ATGAF Unlock Forecast $4496M x 0.6x
ATGFF Unlock Forecast $8814M x 1.2x
ATGPF Unlock Forecast $4154M x 0.6x
BATL Unlock Forecast $19M 1.8x -12.6x
BKV Unlock Forecast $1974M x 1.2x
BRN Unlock Forecast $11M -4.0x 1.3x
BRY Unlock Forecast $232M 46.1x 0.4x
BSM Unlock Forecast $0M x 0.0x
CHRD Unlock Forecast $6429M 24.2x 0.8x
CIVI Unlock Forecast $3429M 5.5x 0.5x
CIVII Unlock Forecast $1M x 0.0x
CJAX Unlock Forecast $50M x 5.8x
CKX Unlock Forecast $23M 64.0x 1.2x
CNX Unlock Forecast $5078M 32.6x 1.2x
CRC Unlock Forecast $4571M 17.3x 1.3x
CRGY Unlock Forecast $0M -1.1x 0.0x
CRK Unlock Forecast $5147M -99.5x 2.3x
CTRA Unlock Forecast $18634M 11.8x 1.3x
DMLP Unlock Forecast $0M 15.1x 0.0x
DVN Unlock Forecast $0M 6.5x 0.0x
EGY Unlock Forecast $405M 10.4x 0.8x
EOG Unlock Forecast $68526M 12.0x 2.3x
EONR Unlock Forecast $15M -0.6x 0.9x
EP Unlock Forecast $181382M -12.0x 3327.8x
EPM Unlock Forecast $174M 48.7x 2.4x
EPSN Unlock Forecast $145M 29.7x 1.5x
EQT Unlock Forecast $36615M 32.0x 1.7x
EXE Unlock Forecast $23288M 113.1x 1.3x
EXEEL Unlock Forecast $19594M 95.1x 1.1x
EXEEW Unlock Forecast $27075M 131.4x 1.5x
EXEEZ Unlock Forecast $23413M 113.7x 1.3x
FANG Unlock Forecast $47699M 12.4x 1.2x
FOMI Unlock Forecast $2M x x
GBR Unlock Forecast $5M 35.1x 1.1x
GPOR Unlock Forecast $3190M 5.7x 1.8x
GRNT Unlock Forecast $726M 22.5x 1.1x
GRVE Unlock Forecast $0M x x
GTE Unlock Forecast $145M 5.1x 0.4x
HESM Unlock Forecast $0M 15.2x 0.0x
HUSA Unlock Forecast $16M 8.2x 1.9x
INDO Unlock Forecast $29M x 1.8x
INR Unlock Forecast $19167M x 1889.7x
IVCP Unlock Forecast $0M x 0.0x
IVCPU Unlock Forecast $0M x 0.0x
IVCPW Unlock Forecast $0M x 0.0x
KOS Unlock Forecast $854M 7.2x 0.8x
KRP Unlock Forecast $0M -1.4x 0.0x
MGY Unlock Forecast $0M 130.8x 0.0x
MNR Unlock Forecast $1641M 7.8x 0.0x
MTDR Unlock Forecast $6716M 7.9x 1.3x
MUR Unlock Forecast $3693M 13.0x 0.7x
MXC Unlock Forecast $17M 10.2x 0.9x
NEHC Unlock Forecast $12M x -2.9x
NOG Unlock Forecast $2608M 4.3x 1.1x
NRIS Unlock Forecast $11M x x
OVV Unlock Forecast $11019M 18.5x 1.1x
OXY Unlock Forecast $47467M 19.8x 1.3x
PARR Unlock Forecast $1815M 2.7x 1.6x
PED Unlock Forecast $53M 4.2x 0.4x
PHX Unlock Forecast $164M 28.4x 1.3x
PNRG Unlock Forecast $270M 9.1x 1.3x
PR Unlock Forecast $10238M 10.9x 1.1x
PROP Unlock Forecast $173M -0.8x 5.1x
REI Unlock Forecast $203M 2.9x 0.2x
REPX Unlock Forecast $645M 6.7x 1.2x
RKDA Unlock Forecast $6M -1.4x 0.9x
ROCL Unlock Forecast $33M -495.5x -7.8x
ROCLU Unlock Forecast $39M x -9.1x
ROCLW Unlock Forecast $1M x -0.3x
RRC Unlock Forecast $8251M 17.2x 2.0x
SD Unlock Forecast $437M 5.8x 0.9x
SM Unlock Forecast $3280M 4.0x 0.7x
SOC Unlock Forecast $2534M x 9.0x
SPOWF Unlock Forecast $0M x x
STR Unlock Forecast $3281M 88.3x 2.3x
TALO Unlock Forecast $1766M 56.7x 0.7x
TPET Unlock Forecast $8M -3.7x 0.7x
TRLEF Unlock Forecast $3M x 3.0x
TTI Unlock Forecast $359M 21.8x 1.3x
TXO Unlock Forecast $642M 50.5x x
USEG Unlock Forecast $40M -1.3x 1.4x
VNOM Unlock Forecast $0M -4.8x 0.0x
VTLE Unlock Forecast $689M 3.8x 0.3x
VTS Unlock Forecast $0M 27.3x 0.0x
WLLBW Unlock Forecast $0M 0.0x 0.0x
WTI Unlock Forecast $269M -7.2x -8.6x

Frequently Asked Questions - Arcadia Biosciences, Inc. Stock Forecast

How accurate are Arcadia Biosciences, Inc. stock predictions?

Our AI model demonstrates 0% historical accuracy for RKDA predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Arcadia Biosciences, Inc. stock price forecasts?

Our analysis considers Arcadia Biosciences, Inc.'s financial metrics, Energy & Transportation sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Arcadia Biosciences, Inc. a good investment in 2025?

Based on our AI analysis, Arcadia Biosciences, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Arcadia Biosciences, Inc. forecasts updated?

Arcadia Biosciences, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Arcadia Biosciences, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Arcadia Biosciences, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...